Sunshine Biopharma's Essential 9 Supplement Marks The Pharma Company's Entry Into $152 Billion Dietary Supplement Market
SponsoredPharmaceutical Companies Report Gearing Up To Combat COVID Variants This Fall
SponsoredSunshine Biopharma Q2 Report Reveals Approximately 1,940% Increase In Cash & Cash Equivalents And 80% Decrease In Net Loss Within 6 Months
SponsoredSunshine Biopharma Extends Aid To The University Of Arizona For Anti-Coronavirus Collaborative Research
SponsoredSunshine Biopharma Recent News
SUNSHINE BIOPHARMA INCREASES SUPPORT FOR ANTI-CORONAVIRUS COLLABORATIVE RESEARCH WITH THE UNIVERSITY OF ARIZONA
Sponsored
Sunshine Biopharma States It Is Developing COVID Antiviral That Could Play Important Role In Treating Endemic COVID
Sponsored
Sunshine Biopharma Prepares For IND Study Of Novel Cancer Drug That It Expects Could Beat Multidrug-Resistant Cancer
Sponsored
Sunshine Biopharma Boasts Of Management Team With Wealth Of Medical And Scientific Knowledge
Sponsored
Sunshine Biopharma Reveals Potential Intellectual Property Position In Connection With Ongoing mRNA-As-Therapeutics-Agents Research
Sponsored
Sunshine Biopharma Files Patent Application Covering Recently Announced mRNA Molecules Found To Be Effective At Destroying Multidrug Resistant Cancer Cells
Sponsored
EXCLUSIVE: Sunshine Biopharma Looks Ahead In COVID And Cancer Treatments
Sunshine Biopharma Sees Potential Multi-Billion Dollar Global Market Opportunity As Research Findings Reveal Effectiveness Against Multidrug-Resistant Cancer Cells
Sponsored
Sunshine Biopharma's $8 Million Private Placement Injects New Funding For Drug Development
Sponsored
Sunshine Biopharma, Inc. Announces Pricing of $8 Million Private Placement Priced At-the-Market
Sponsored
Sunshine Biopharma, Inc. Announces Closing of $8 Million Public Offering and Uplisting to the Nasdaq Capital Market
Sponsored